ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
안면신경마비 시장 규모는 향후 몇 년 동안 강력한 성장이 예상됩니다. 2029년에는 CAGR 5.0%로 29억 1,000만 달러로 성장할 것입니다. 예측 기간의 성장은 치료 옵션의 증가, 안면 신경 장애의 유병률 증가, 안면 미용에 대한 인식 증가, 전 세계 노인 인구의 증가, 바이러스 감염의 의미 증가에 기인하는 것으로 보입니다. 예측 기간의 주요 동향으로는 기술 통합, 맞춤형 의료의 발전, 새로운 수술 기법 도입, 혁신적인 수술 기법 개발, 신경 재생의 발전, 재활치료에 가상현실의 통합, 기술 발전 등을 들 수 있습니다.
향후 5년간 성장률 5.0%라는 예측은 지난번 예측보다 0.1% 소폭 하락한 수치입니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향에 기인합니다. 관세 인상은 독일과 일본에서 수입되는 신경근 전기자극기 및 수술용 신경이식재 비용을 상승시키고, 재활을 지연시키고, 안면 재건 수술 비용을 증가시켜 미국 환자들에게 부담을 줄 가능성이 높습니다. 또한, 상호 관세와 무역 긴장과 제한의 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향은 더욱 광범위하게 나타날 것으로 보입니다.
바이러스 감염증의 영향 확대는 향후 안면신경마비 시장의 확대를 촉진할 것으로 예상됩니다. 미생물에 의한 바이러스 감염은 신체의 다양한 부위에 영향을 미쳐 다양한 증상과 건강 문제를 일으킬 수 있습니다. 바이러스 감염증의 증가는 전 세계 여행 트렌드, 환경 변화, 항균제 내성, 사회경제적 요인, 바이러스 진화 등의 영향을 받고 있습니다. 이러한 감염은 안면신경에 염증을 일으켜 손상시키고 안면신경이 얼굴 근육을 조절하는 능력을 손상시켜 일시적 또는 영구적인 근력 약화 또는 마비를 일으켜 안면신경마비를 유발할 수 있습니다. 예를 들어, 미국 질병통제예방센터(CDC)의 보고에 따르면, 2022년 10월 미국의 인플루엔자 관련 질병 발병률은 인구 10만 명당 949만 7,254명으로 2021년 대비 46% 증가하였다고 합니다. 그 결과, 바이러스 감염의 의미가 높아지면서 안면신경마비 시장의 성장에 박차를 가하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 안면신경마비 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업 분석
세계의 안면신경마비 시장 : 성장률 분석
세계의 안면신경마비 시장 실적 : 규모와 성장, 2019-2024
세계의 안면신경마비 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계의 안면신경마비 : 총 잠재 시장 규모(TAM)
제6장 시장 세분화
세계의 안면신경마비 시장 : 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
벨 마비
람제이·헌트 증후군
세계의 안면신경마비 시장 진단별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
근전도 검사
컴퓨터 단층촬영
세계의 안면신경마비 시장 : 치료별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
의약품
물리치료
세계의 안면신경마비 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
병원
전문 센터
세계의 안면신경마비 시장 : 하위 세분화 벨 마비 종류, 실적과 예측, 2019-2024, 2024-2029F, 2034F
특발성 벨 마비
산후 벨 마비
소아 벨 마비
세계의 안면신경마비 시장 : 하위 세분화 람제이·헌트 증후군(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
유형 1(귀 대상포진)
2형(수두 대상포진 바이러스)
제7장 지역별·국가별 분석
세계의 안면신경마비 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세계의 안면신경마비 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
안면신경마비 시장 : 경쟁 구도
안면신경마비 시장 : 기업 개요
Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업과 혁신적 기업
Bayer AG
Sanofi SA
Bristol-Myers Squibb and Company
AstraZeneca plc
Abbott Laboratories
Novartis AG
GlaxoSmithKline Plc
Takeda Pharmaceutical Company Limited
Medtronic plc
Eli Lilly and Company
Stryker Corporation
Boston Scientific Corporation
Astellas Pharma Inc.
Ipsen S.A.
Santen Pharmaceutical Ltd.
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병
제34장 최근의 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
안면신경마비 시장 2029 : 새로운 기회를 제공하는 국가
안면신경마비 시장 2029 : 새로운 기회를 제공하는 부문
안면신경마비 시장 2029 : 성장 전략
시장 동향에 기반한 전략
경쟁 전략
제36장 부록
KSM
영문 목차
영문목차
Facial paralysis involves difficulty or inability to move facial muscles due to damage or dysfunction of the facial nerve. This condition can affect one or both sides of the face, leading to varying degrees of weakness or immobility, such as trouble closing the eye, smiling, or making facial expressions. Facial paralysis may develop suddenly (acute) or over time (chronic) and can result from conditions such as Bell's palsy, stroke, trauma, infections, tumors, or neurological disorders.
In the facial paralysis market, the primary types are Bell's palsy and Ramsay Hunt syndrome. Bell's palsy is marked by sudden, temporary weakness or paralysis of muscles on one side of the face. Diagnostic methods include electromyography and computerized tomography, while treatment options involve medications and physical therapy. The main end-users of these treatments are hospitals and specialty centers.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The facial paralysis market research report is one of a series of new reports from The Business Research Company that provides facial paralysis market statistics, including the facial paralysis industry global market size, regional shares, competitors with facial paralysis market share, detailed facial paralysis market segments, market trends, and opportunities, and any further data you may need to thrive in the facial paralysis industry. These facial paralysis market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The facial paralysis market size has grown strongly in recent years. It will grow from $2.28 billion in 2024 to $2.4 billion in 2025 at a compound annual growth rate (CAGR) of 5.1%. The growth in the historic period can be attributed to rise in prevalence of facial paralysis, rise in need for therapies for the condition, increase in government backing, rise in demand for technologically sophisticated therapies, and rise in need for minimally invasive procedures.
The facial paralysis market size is expected to see strong growth in the next few years. It will grow to $2.91 billion in 2029 at a compound annual growth rate (CAGR) of 5.0%. The growth in the forecast period can be attributed to increasing treatment options, increasing prevalence of facial nerve disorders, growing awareness about facial aesthetics, rising geriatric population globally, and rising implications of viral infections. Major trends in the forecast period include technology integration, advancements in personalized medicine, introduction of novel surgical techniques, development of innovative surgical techniques, advancements in nerve regeneration, integration of virtual reality in rehabilitation, and technological advancements.
The forecast of 5.0% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. patients by driving up the cost of neuromuscular electrical stimulators and surgical nerve grafts imported from Germany and Japan, delaying rehabilitation and increasing facial reconstructive surgery costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The growing impact of viral infections is anticipated to drive the expansion of the facial paralysis market in the future. Viral infections, caused by microscopic organisms, can affect various body parts and lead to a range of symptoms and health issues. The increase in viral infections is influenced by global travel trends, environmental changes, antimicrobial resistance, socioeconomic factors, and viral evolution. These infections can cause facial paralysis by inflaming and damaging the facial nerve, disrupting its ability to control facial muscles, and leading to temporary or permanent weakness or paralysis. For example, the Centers for Disease Control and Prevention reported that, in October 2022, the incidence of influenza-associated diseases in the US was 9,497,254 per 100,000 people, marking a 46% increase from 2021. Consequently, the growing implications of viral infections are fueling the growth of the facial paralysis market.
Key players in the facial paralysis market are concentrating on creating innovative solutions, such as neuromuscular blockade monitors, to improve patient convenience and accessibility, facilitating effective home-based rehabilitation and therapy. A neuromuscular blockade monitor, specifically a facial nerve monitor, is a specialized device designed to evaluate the function and response of facial muscles during surgical procedures involving neuromuscular blocking agents (NMBAs). For instance, in October 2022, Nihon Kohden Corporation, a Japanese manufacturer of medical electronic equipment, introduced the Smart Cable NMT Pod and disposable electrodes for neuromuscular blockade monitoring. This product, utilizing electromyography, accurately measures paralysis levels through peripheral nerve stimulation. The Smart Cable NMT Pod is a compact, portable device with neuromuscular transmission (NMT) monitoring capabilities, enabling clinicians to track a patient's muscle relaxation during surgery. Neuromuscular monitoring and electrical stimulation of facial muscles may also aid in the rehabilitation of patients with Bell's palsy.
In September 2022, Brainlab, a digital medical technology company based in Germany, acquired Dr. Langer Medical GmbH for an undisclosed amount. This acquisition is intended to create synergies within Brainlab's digital surgery ecosystem and align its entrepreneurial efforts with innovation potential. Dr. Langer Medical GmbH, also based in Germany, specializes in intraoperative neuromonitoring (IONM) solutions, particularly for surgeries involving the facial nerve.
Major companies operating in the facial paralysis market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi SA, Bristol-Myers Squibb and Company, AstraZeneca plc, Abbott Laboratories, Novartis AG, GlaxoSmithKline Plc, Takeda Pharmaceutical Company Limited, Medtronic plc, Eli Lily and Company, Stryker Corporation, Boston Scientific Corporation, Astellas Pharma Inc., Ipsen S.A., Santen Pharmaceutical Ltd., Merz Pharma GmbH & Co. KGaA, Bioventus LLC, Revance Therapeutics Inc., BioControl Medical Ltd., Sucampo Pharmaceuticals Inc.
North America was the largest region in the facial paralysis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the market going forward. The regions covered in the facial paralysis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the facial paralysis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The facial paralysis market consists of revenues earned by entities by providing services such as surgical interventions, nerve grafts, consultations, diagnostic tests, and muscle transfers procedures. The market value includes the value of related goods sold by the service provider or included within the service offering. The facial paralysis market also includes sales of electromyography machines, TENS units, facial rehabilitation devices, botox injections, nerve graft materials, and facial implants. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Facial Paralysis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on facial paralysis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for facial paralysis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The facial paralysis market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Type: Bell's Palsy; Ramsay Hunt Syndrome
2) By Diagnosis: Electromyography; Computerized Tomography
3) By Treatment: Medications; Physical Therapy
4) By End-User: Hospitals; Specialty Centers
Subsegments:
1) By Bell's Palsy: Idiopathic Bell's Palsy; Postpartum Bell's Palsy; Bell's Palsy in Children
2) By Ramsay Hunt Syndrome: Type 1 (Herpes Zoster Oticus); Type 2 (Varicella-Zoster Virus)
Companies Mentioned: Pfizer Inc.; Johnson & Johnson; F. Hoffmann-La Roche AG; Merck & Co. Inc.; AbbVie Inc.; Bayer AG; Sanofi SA; Bristol-Myers Squibb and Company; AstraZeneca plc; Abbott Laboratories; Novartis AG; GlaxoSmithKline Plc; Takeda Pharmaceutical Company Limited; Medtronic plc; Eli Lily and Company; Stryker Corporation; Boston Scientific Corporation; Astellas Pharma Inc.; Ipsen S.A.; Santen Pharmaceutical Ltd.; Merz Pharma GmbH & Co. KGaA; Bioventus LLC; Revance Therapeutics Inc.; BioControl Medical Ltd.; Sucampo Pharmaceuticals Inc.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Facial Paralysis Market Characteristics
3. Facial Paralysis Market Trends And Strategies
4. Facial Paralysis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Facial Paralysis Growth Analysis And Strategic Analysis Framework
5.1. Global Facial Paralysis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Facial Paralysis Market Growth Rate Analysis
5.4. Global Facial Paralysis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Facial Paralysis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Facial Paralysis Total Addressable Market (TAM)
6. Facial Paralysis Market Segmentation
6.1. Global Facial Paralysis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Bell's Palsy
Ramsay Hunt Syndrome
6.2. Global Facial Paralysis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Electromyography
Computerized Tomography
6.3. Global Facial Paralysis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Medications
Physical Therapy
6.4. Global Facial Paralysis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Specialty Centers
6.5. Global Facial Paralysis Market, Sub-Segmentation Of Bell's Palsy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Idiopathic Bell's Palsy
Postpartum Bell's Palsy
Bell's Palsy in Children
6.6. Global Facial Paralysis Market, Sub-Segmentation Of Ramsay Hunt Syndrome, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Type 1 (Herpes Zoster Oticus)
Type 2 (Varicella-Zoster Virus)
7. Facial Paralysis Market Regional And Country Analysis
7.1. Global Facial Paralysis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Facial Paralysis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
